Impact of methamphetamine on infection and immunity

Sergio A. Salamanca, Edra E. Sorrentino, Joshua D. Nosanchuk, Luis R. Martinez

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The prevalence of methamphetamine (METH) use is estimated at ∼35 million people worldwide, with over 10 million users in the United States. METH use elicits a myriad of social consequences and the behavioral impact of the drug is well understood. However, new information has recently emerged detailing the devastating effects of METH on host immunity, increasing the acquisition of diverse pathogens and exacerbating the severity of disease. These outcomes manifest as modifications in protective physical and chemical defenses, pro-inflammatory responses, and the induction of oxidative stress pathways. Through these processes, significant neurotoxicities arise, and, as such, chronic abusers with these conditions are at a higher risk for heightened consequences. METH use also influences the adaptive immune response, permitting the unrestrained development of opportunistic diseases. In this review, we discuss recent literature addressing the impact of METH on infection and immunity, and identify areas ripe for future investigation.

Original languageEnglish (US)
Article number445
JournalFrontiers in Neuroscience
Volume9
Issue numberJAN
DOIs
StatePublished - 2015

Fingerprint

Methamphetamine
Immunity
Infection
Adaptive Immunity
Oxidative Stress
Pharmaceutical Preparations

Keywords

  • Drug abuse
  • HIV
  • Immunity
  • Infectious diseases
  • Methamphetamine
  • Neurotoxicity

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Impact of methamphetamine on infection and immunity. / Salamanca, Sergio A.; Sorrentino, Edra E.; Nosanchuk, Joshua D.; Martinez, Luis R.

In: Frontiers in Neuroscience, Vol. 9, No. JAN, 445, 2015.

Research output: Contribution to journalArticle

Salamanca, Sergio A. ; Sorrentino, Edra E. ; Nosanchuk, Joshua D. ; Martinez, Luis R. / Impact of methamphetamine on infection and immunity. In: Frontiers in Neuroscience. 2015 ; Vol. 9, No. JAN.
@article{f8f7d67cf09241a887a3c7d21477226c,
title = "Impact of methamphetamine on infection and immunity",
abstract = "The prevalence of methamphetamine (METH) use is estimated at ∼35 million people worldwide, with over 10 million users in the United States. METH use elicits a myriad of social consequences and the behavioral impact of the drug is well understood. However, new information has recently emerged detailing the devastating effects of METH on host immunity, increasing the acquisition of diverse pathogens and exacerbating the severity of disease. These outcomes manifest as modifications in protective physical and chemical defenses, pro-inflammatory responses, and the induction of oxidative stress pathways. Through these processes, significant neurotoxicities arise, and, as such, chronic abusers with these conditions are at a higher risk for heightened consequences. METH use also influences the adaptive immune response, permitting the unrestrained development of opportunistic diseases. In this review, we discuss recent literature addressing the impact of METH on infection and immunity, and identify areas ripe for future investigation.",
keywords = "Drug abuse, HIV, Immunity, Infectious diseases, Methamphetamine, Neurotoxicity",
author = "Salamanca, {Sergio A.} and Sorrentino, {Edra E.} and Nosanchuk, {Joshua D.} and Martinez, {Luis R.}",
year = "2015",
doi = "10.3389/fnins.2014.00445",
language = "English (US)",
volume = "9",
journal = "Frontiers in Neuroscience",
issn = "1662-4548",
publisher = "Frontiers Research Foundation",
number = "JAN",

}

TY - JOUR

T1 - Impact of methamphetamine on infection and immunity

AU - Salamanca, Sergio A.

AU - Sorrentino, Edra E.

AU - Nosanchuk, Joshua D.

AU - Martinez, Luis R.

PY - 2015

Y1 - 2015

N2 - The prevalence of methamphetamine (METH) use is estimated at ∼35 million people worldwide, with over 10 million users in the United States. METH use elicits a myriad of social consequences and the behavioral impact of the drug is well understood. However, new information has recently emerged detailing the devastating effects of METH on host immunity, increasing the acquisition of diverse pathogens and exacerbating the severity of disease. These outcomes manifest as modifications in protective physical and chemical defenses, pro-inflammatory responses, and the induction of oxidative stress pathways. Through these processes, significant neurotoxicities arise, and, as such, chronic abusers with these conditions are at a higher risk for heightened consequences. METH use also influences the adaptive immune response, permitting the unrestrained development of opportunistic diseases. In this review, we discuss recent literature addressing the impact of METH on infection and immunity, and identify areas ripe for future investigation.

AB - The prevalence of methamphetamine (METH) use is estimated at ∼35 million people worldwide, with over 10 million users in the United States. METH use elicits a myriad of social consequences and the behavioral impact of the drug is well understood. However, new information has recently emerged detailing the devastating effects of METH on host immunity, increasing the acquisition of diverse pathogens and exacerbating the severity of disease. These outcomes manifest as modifications in protective physical and chemical defenses, pro-inflammatory responses, and the induction of oxidative stress pathways. Through these processes, significant neurotoxicities arise, and, as such, chronic abusers with these conditions are at a higher risk for heightened consequences. METH use also influences the adaptive immune response, permitting the unrestrained development of opportunistic diseases. In this review, we discuss recent literature addressing the impact of METH on infection and immunity, and identify areas ripe for future investigation.

KW - Drug abuse

KW - HIV

KW - Immunity

KW - Infectious diseases

KW - Methamphetamine

KW - Neurotoxicity

UR - http://www.scopus.com/inward/record.url?scp=84921796188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921796188&partnerID=8YFLogxK

U2 - 10.3389/fnins.2014.00445

DO - 10.3389/fnins.2014.00445

M3 - Article

AN - SCOPUS:84921796188

VL - 9

JO - Frontiers in Neuroscience

JF - Frontiers in Neuroscience

SN - 1662-4548

IS - JAN

M1 - 445

ER -